European policy reform is needed to attract investment and bolster local production of essential medicines in a context in which “Europe’s strategic autonomy is waning,” Teva has urged in a detailed new report.
Titled “Addressing Europe’s Essential Medicines Exodus,” the report “provides EU policy makers with a case for enhancing pharmaceutical manufacturing...




